Tobias Carling

Parathyroid tumors.

Multiple endocrine neoplasia syndrome: genetic basis for clinical management.

Follicular neoplasms of the thyroid: what to recommend.

Minimally invasive parathyroidectomy using cervical block: reasons for conversion to general anesthesia.

Diagnosis and treatment of interval sentinel lymph nodes in patients with cutaneous melanoma.

Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer?

Defining surgical therapy for pseudomembranous colitis with toxic megacolon.

Focused approach to parathyroidectomy.

Multinodular goiter and primary hyperparathyroidism: a circuitous route to diagnosing metastatic uveal melanoma.

Molecular genetics of gastroenteropancreatic neuroendocrine tumors.

Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer.

Retroperitoneal endoscopic adrenalectomy is safe and effective (Br J Surg 2010; 97:1667-1672).

Expression and somatic mutations of SDHAF2 (SDH5), a novel endocrine tumor suppressor gene in parathyroid tumors of primary hyperparathyroidism.

Clinical and histopathological characteristics of hyperparathyroidism-induced hypercalcemic crisis.

4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism.

K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

The DNA methylome of benign and malignant parathyroid tumors.

Minimally invasive parathyroidectomy.

The role of epigenetic alterations in papillary thyroid carcinogenesis.

Spontaneous adrenal hemorrhage with associated masses: etiology and management in 6 cases and a review of 133 reported cases.

Parathyroid four-dimensional computed tomography: evaluation of radiation dose exposure during preoperative localization of parathyroid tumors in primary hyperparathyroidism.

Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism.

Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.

Surgical approach and outcomes in patients with lithium-associated hyperparathyroidism.

Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.

Identification of somatic mutations in parathyroid tumors using whole-exome sequencing.

Vanishing thyroid tumors: a diagnostic dilemma after ultrasonography-guided fine-needle aspiration.

Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.

Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma.

Thyroid cancer.

Follicular variant of papillary thyroid carcinoma: accuracy of FNA diagnosis and implications for patient management.

Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.

Risk stratification in follicular neoplasm: a cytological assessment using the modified Bethesda classification.

Gene expression and regulation in adrenocortical tumorigenesis.

Subclinical Cushing syndrome: a review.

Surgery for thyroid cancer.

Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.

Modern experience with aggressive parathyroid tumors in a high-volume New England referral center.

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas.

Real-Time Super Selective Venous Sampling in Remedial Parathyroid Surgery.

Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.

Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype.

Absence of KMT2D/MLL2 mutations in abdominal paraganglioma.

Chromosome 19 amplification correlates with advanced disease in adrenocortical carcinoma.

DNA copy amplification and overexpression of SLC12A7 in adrenocortical carcinoma.

Dissection of Levels II Through V Is Required for Optimal Outcomes in Patients with Lateral Neck Lymph Node Metastasis from Papillary Thyroid Carcinoma.

Pregnancy, Primary Aldosteronism, and Somatic CTNNB1 Mutations.

Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma.

Primary hyperparathyroidism with normal baseline intraoperative parathyroid hormone: A challenging population.

Parathyroidectomy prior to kidney transplant decreases graft failure.

Suppression of cytochrome P450 4B1: An early event in adrenocortical tumorigenesis.

Overexpression of cytochrome P450 2A6 in adrenocortical carcinoma.

A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis.

Primary hyperparathyroidism treated by transoral endoscopic parathyroidectomy vestibular approach (TOEPVA).

Epigenetic modifications in poorly differentiated and anaplastic thyroid cancer.

Advances in understanding the molecular underpinnings of adrenocortical tumors.

DNA Mismatch Repair Deficiency Promotes Genomic Instability in a Subset of Papillary Thyroid Cancers.

Mutational Analysis ofin Sporadic Parathyroid Adenomas.

Hyperparathyroidism-Jaw Tumor Syndrome Associated With Large-Scale 1q31 Deletion.

BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.

Whole-Exome Sequencing Identifies Two Discrete Druggable Signaling Pathways in Follicular Thyroid Cancer.